Ledger.Open graph →
SEC Form D · filed January 4, 2021

Cyclacel Pharmaceuticals, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY HEIGHTS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Spiro Rombotis · Berkeley Heights, NJExec · DirectorKarin L. Walker · Berkeley Heights, NJDirectorChristopher S. Henney · Berkeley Heights, NJDirectorSamuel L. Barker · Berkeley Heights, NJDirectorBrian L. Schwartz · Berkeley Heights, NJDirectorPaul Mcbarron · Berkeley Heights, NJExec · DirectorGregory T. Hradsky · Berkeley Heights, NJDirectorLloyd T. Sems · Berkeley Heights, NJDirectorJordan E. Cherry · Birmingham, ALDirectorWilliam A. Levant, Iii · Birmingham, ALDirectorRobert J. Speigel · Berkeley Heights, NJDirectorMark H. Kirschbaum · Berkeley Heights, NJExecGreg T. Herring · ELBERTON, GADirectorL. J. Mcconnell, Jr · ELBERTON, GADirectorRobert J. Speigel · Berkeley Heights, NJDirectorMark H. Kirschbaum · Berkeley Heights, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗